Adrenal metastases

被引:13
作者
Wagnerova, H. [1 ]
Lazurova, I [1 ]
Felsoci, M. [1 ]
机构
[1] PJ Safarikiensis Univ, Fac Med, Dept Internal Med 1, SK-04011 Kosice, Slovakia
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2013年 / 114卷 / 04期
关键词
adrenal metastases; imaging of adrenal tumors; adrenal incidentalomas; pheochromocytoma; CHEMICAL-SHIFT; MASSES; CT; LESIONS; CANCER; INCIDENTALOMAS; CARCINOMA; DIAGNOSIS; MELANOMA; HISTORY;
D O I
10.4149/BLL_2013_049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The adrenal gland is a frequent location for metastatic spread of a various number of malignant tumors. Among all tumors, carcinoma of lung, breast, ovary and malignant melanoma count to the most frequent ones. In nononcological and unselected populations, the prevalence of adrenal metastases is 0-21 %. The metastases are mostly discovered in patients during their follow-up carried out in consequence of their antecedent malignant disease. A malignant disease in adrenal gland may occasionally manifest as a solitary metastasis referred to as adrenal incidentaloma. If the malignant disease is disseminated at the time of adrenal mass diagnosis, no further differentiation of lesion is necessary as it does not influence the further therapeutic process. If the dissemination is not present, further differentiation of adrenal lesion is essential. CT and MRI characteristics of the adrenal mass play the key role in the differential diagnosis. The examination of adrenal overproduction is not necessary in case of known adrenal metastasis except when performing tests in order to rule out the catecholamine overproduction. In case of bilateral metastases, adrenal insufficiency should be also excluded. Surgical treatment is indicated in cases of solitary metastasis. The further management of patients with adrenal metastases belongs to the oncologist. The prognosis of the disease is usually very poor with average survival rate of three months (Fig. 2, Ref. 34). Full Text in PDF www.elis.sk.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 35 条
[1]  
ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO
[2]  
2-7
[3]   Isolated adrenal mass in patients with a history of cancer: Remember pheochromocytoma [J].
Adler, Joel T. ;
Mack, Eberhard ;
Chen, Herbert .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (08) :2358-2362
[4]  
[Anonymous], 2009, ENDOCR PRACT, DOI [DOI 10.4158/EP.15.5.450, 10.4158/ep.15.s1.1]
[5]   Characterization of adrenal masses using unenhanced CT: An analysis of the CT literature [J].
Boland, GWL ;
Lee, MJ ;
Gazelle, GS ;
Halpern, EF ;
McNicholas, MMJ ;
Mueller, PR .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (01) :201-204
[6]  
Bui CH, 2006, ENDOCRINOLOGY, P2425
[7]   Adrenal masses: Characterization with combined unenhanced and delayed enhanced CT [J].
Caoili, EM ;
Korobkin, M ;
Francis, IR ;
Cohan, RH ;
Platt, JF ;
Dunnick, NR ;
Raghupathi, KI .
RADIOLOGY, 2002, 222 (03) :629-633
[8]   Imaging-guided percutaneous radiofrequency ablation of adrenal metastases:: Preliminary results at a single institution with a single device [J].
Carrafiello, G. ;
Lagana, D. ;
Recaldini, C. ;
Giorgianni, A. ;
Ianniello, A. ;
Lumia, D. ;
D'Ambrosio, A. ;
Petulla, M. ;
Dionigi, G. ;
Fugazzola, C. .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2008, 31 (04) :762-767
[9]   Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? [J].
Cawood, T. J. ;
Hunt, P. J. ;
O'Shea, D. ;
Cole, D. ;
Soule, S. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (04) :513-527
[10]  
DASGUPTA T, 1964, CANCER-AM CANCER SOC, V17, P1323